2.07
Precedente Chiudi:
$2.07
Aprire:
$2.07
Volume 24 ore:
74,679
Relative Volume:
0.30
Capitalizzazione di mercato:
$35.86M
Reddito:
-
Utile/perdita netta:
-
Rapporto P/E:
-
EPS:
-
Flusso di cassa netto:
-
1 W Prestazione:
+0.00%
1M Prestazione:
+11.89%
6M Prestazione:
-39.65%
1 anno Prestazione:
-34.29%
Mural Oncology Plc Stock (MURA) Company Profile
Nome
Mural Oncology Plc
Settore
Industria
Telefono
353 1 905 8020
Indirizzo
10 EARLSFORT TERRACE, DUBLIN 2
Confronta MURA con altri titoli
Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
---|---|---|---|---|---|---|
![]()
MURA
Mural Oncology Plc
|
2.07 | 36.04M | 0 | 0 | 0 | 0.00 |
![]()
VRTX
Vertex Pharmaceuticals Inc
|
396.93 | 102.81B | 11.39B | 3.64B | 3.50B | 13.99 |
![]()
ALNY
Alnylam Pharmaceuticals Inc
|
453.54 | 58.59B | 2.46B | -319.09M | -52.09M | -2.47 |
![]()
REGN
Regeneron Pharmaceuticals Inc
|
567.22 | 61.25B | 14.21B | 4.46B | 3.56B | 39.68 |
![]()
ARGX
Argen X Se Adr
|
733.66 | 43.23B | 3.06B | 1.28B | 447.35M | 21.30 |
![]()
ONC
Beone Medicines Ltd Adr
|
318.73 | 36.53B | 3.81B | -644.79M | -669.77M | -6.24 |
Mural Oncology Plc Stock (MURA) Upgrades & Downgrades
Data | Azione | Analista | Modifica della valutazione |
---|---|---|---|
2025-03-25 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
2025-03-25 | Downgrade | Raymond James | Strong Buy → Outperform |
2024-06-28 | Iniziato | Rodman & Renshaw | Buy |
2024-04-04 | Iniziato | Morgan Stanley | Overweight |
Mural Oncology Plc Borsa (MURA) Ultime notizie
Does Mural Oncology plc fit your quant trading modelPortfolio Update Report & High Yield Stock Recommendations - Newser
Can Mural Oncology plc recover in the next quarter2025 Year in Review & Free High Accuracy Swing Entry Alerts - Newser
What is Mural Oncology plc s 5 year growth outlookExit Point & Fast Entry High Yield Tips - khodrobank.com
Citadel Group discloses 1.68% stake in Mural Oncology - Investing.com
Form 8.3Mural Oncology plc - Business Wire
How to forecast Mural Oncology plc trends using time seriesEarnings Recap Report & AI Driven Stock Reports - Newser
Mural Oncology plc’s volatility index tracking explainedAnalyst Downgrade & High Yield Stock Recommendations - Newser
Is it time to cut losses on Mural Oncology plcJuly 2025 Technicals & Verified Entry Point Signals - Newser
Using RSI to spot recovery in Mural Oncology plc2025 Institutional Moves & Weekly Market Pulse Updates - Newser
What institutional flow reveals about Mural Oncology plcJuly 2025 Big Picture & High Accuracy Trade Signal Alerts - Newser
Heatmap analysis for Mural Oncology plc and competitorsBear Alert & Momentum Based Trading Signals - Newser
Technical signs of recovery in Mural Oncology plcJuly 2025 Rallies & Low Drawdown Trading Strategies - Newser
Sector ETF performance correlation with Mural Oncology plcJuly 2025 Trade Ideas & Fast Moving Stock Trade Plans - Newser
Evaluating Mural Oncology plc with trendline analysisGlobal Markets & Entry Point Confirmation Signals - Newser
Using flow based indicators on Mural Oncology plcMarket Rally & Weekly Market Pulse Updates - Newser
Is Mural Oncology plc reversing from oversold territory2025 Geopolitical Influence & Weekly High Momentum Picks - Newser
Will breakout in Mural Oncology plc lead to full recoveryWeekly Market Report & Low Drawdown Momentum Ideas - Newser
Insider Buy: Is Mural Oncology plc’s ROE strong enoughJuly 2025 Update & Expert-Curated Trade Recommendations - khodrobank.com
Using AI based signals to follow Mural Oncology plc2025 Market Sentiment & Reliable Intraday Trade Alerts - Newser
Is Mural Oncology plc stock influenced by commodity pricesJuly 2025 EndofMonth & Verified Entry Point Signals - khodrobank.com
Is Mural Oncology plc a strong candidate for buy and holdQuarterly Market Summary & Accurate Entry/Exit Alerts - khodrobank.com
Is Mural Oncology plc stock suitable for long term investingJuly 2025 Macro Moves & Daily Stock Momentum Reports - خودرو بانک
What to expect from Mural Oncology plc in the next 30 daysPortfolio Risk Summary & Accurate Buy Signal Alerts - Newser
Support Zone Holds Steady for IIPR After Dip getLinesFromResByArray error: size == 0 - thegnnews.com
Is Mural Oncology plc vulnerable to short sellersQuarterly Growth Report & Safe Entry Zone Identification - khodrobank.com
Take Profit: What dividend growth rate does Mural Oncology plc offerEarnings Beat & Real-Time Volume Analysis - khodrobank.com
Will Mural Oncology plc benefit from rising consumer demandWeekly Gains Report & Real-Time Stock Price Movement Reports - khodrobank.com
Volume spikes in Mural Oncology plc stock – what they meanJuly 2025 Chart Watch & Reliable Momentum Entry Alerts - Newser
Technical Heatmap Flags Mural Oncology plc for WatchJuly 2025 Pullbacks & Fast Momentum Entry Tips - beatles.ru
Citadel Group discloses 1.54% stake in Mural Oncology - Investing.com
Citadel Group discloses 1.54% stake in Mural Oncology By Investing.com - Investing.com UK
Candlestick signals on Mural Oncology plc stock today2025 Earnings Impact & Fast Moving Trade Plans - Newser
Will Mural Oncology plc be affected by tariffsWall Street Watch & Fast Momentum Entry Tips - khodrobank.com
Technical Heatmap Flags Mural Oncology plc for Watch getLinesFromResByArray error: size == 0 - 더경남뉴스
Is Mural Oncology plc stock poised for growthWeekly Risk Report & High Yield Equity Trading Tips - Newser
Mural Oncology Plc Azioni (MURA) Dati Finanziari
Non sono disponibili dati finanziari per Mural Oncology Plc (MURA). Controlla altri titoli per ulteriori informazioni.
Reddito
Reddito netto
Flusso di cassa
EPS
Mural Oncology Plc Azioni (MURA) insider trading
Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
---|---|---|---|---|---|---|---|
Keson-Brookes Maiken | See Remarks |
Jul 18 '25 |
Sale |
2.48 |
2,158 |
5,352 |
71,406 |
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):